European Association for Hemophilia and Allied Disorders (EAHAD 2026) 3 - 6 February 2026

Concizumab efficacy in Haemophilia A/B in an Intra-Patient Comparison vs Previous prophylaxis (Phase 3 Explorer8 study): Post-hoc Sensitivity Analysis

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Rare Blood Disorders
Congress poster
Concizumab